A workshop entitled 'Developmental Immunotoxicology and Risk Assessment' was held on 12-13 June 2001, in Washington, DC.
Developmental Immunotoxicology and Risk Assessment: A Workshop Summary
Human & Experimental Toxicology, 2012
Open access, peer-reviewed publications ensure that knowledge is a public good. HESI believes that accessible research is critical for equitable engagement, diverse collaboration, and increased interdisciplinary conversation. We strive to achieve open access on all publications, and more than 200 publications from HESI programs have been published in the last decade.
Human & Experimental Toxicology, 2012
A workshop entitled 'Developmental Immunotoxicology and Risk Assessment' was held on 12-13 June 2001, in Washington, DC.
Toxicologic Pathology, 2012
Developmental immunotoxicity (DIT) testing is centered around the concern that exposure to immunotoxicants early in development may result in enhanced susceptibility of, or unique or more persistent effects on, the immune system, in comparison to adult exposure.
Current Protocols in Toxicology, 2012
Standard protocols are given for assessing metabolic stability in rainbow trout using the liver S9 fraction.
Journal of Immunotoxicology, 2012
Epstein-Barr virus (EBV)-associated lymphomas are a known risk for immunosuppressed individuals.
Toxicological Sciences, 2012
The practice of toxicology is changing rapidly, as demonstrated by the response to the 2007 NRC report on "Toxicity Testing in the 21(st) Century."
Journal of Immunotoxicology, 2012
While immunotoxicology evaluations are often conducted in either rodents or non-human primates, findings in standard toxicology studies may trigger additional investigations in dogs.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.